|
|
||||||||
CALL FOR PAPERS
Baroreflex Control of Sodium Excretion and Arterial Pressure
Circulatory Control Laboratory, Department of Physiology, University of Auckland, Auckland, New Zealand
| ABSTRACT |
|---|
|
|
|---|
baroreflex resetting; sinoaortic denervation; renal sympathetic nerve activity
| FIRST ARGUMENT AGAINST ARTERIAL BAROREFLEXES PLAYING A ROLE IN THE LONG-TERM CONTROL OF ARTERIAL PRESSURE: THE RESETTING PHENOMENA |
|---|
|
|
|---|
Differential Baroreflex Resetting
A common assumption made is that if one component of the baroreflex resets, all components must; e.g., if heart rate control is reset then so must sympathetic activity to the kidneys, muscle, skin, etc. In reality it is entirely possible that different components of the baroreflex may be more or less sensitive to sustained changes in pressure. Even at the level of the baroreceptor endings themselves there is evidence that the baroreceptors are capable of providing information about both the absolute and relative level of pressure. The baroreceptor afferents are composed of both A and C fibers. Typically, C fibers have a much lower firing frequency and higher pressure threshold than A fibers (53). Even at normal resting arterial pressures it appears that, while most A fibers are active, many C fibers are still below threshold (9). One possibility is that the A fibers are important in buffering rapid changes in pressure, and reset readily whereas the C fibers are more important in preventing high pressures and are less likely to reset (48). In explaining the greater shift in the response curve at threshold pressures than at higher pressures seen in whole nerve recordings, both Undesser et al. (55) and Heesch et al. (19) speculated that the low-threshold receptors may reset more readily than high-threshold baroreceptors.
There is also evidence to suggest that the different subtypes of baroreceptor afferents may project to different regions of the nucleus tractus solitarius (13) and ultimately have control over different reflex pathways (14). Sympathetic nerve activity (SNA) to the renal, muscle and heart is strongly baroreflex modulated yet SNA to the skin and gut much less so (23, 3840). It is perhaps not surprising then that just because one branch of the efferent baroreflex pathway may reset, this does not necessarily mean all reflex pathways will be reset similarly. Even in acute experiments where the baroreceptor afferents have been stimulated electrically it has been shown that when the stimulation stops arterial pressure returns to resting levels much quicker than renal sympathetic nerve activity (26). Disparities in the way in which heart rate and renal SNA reset in response to a two-kidney, one-clip model of hypertension have also been observed, with an attenuation of the arterial baroreflex control of renal SNA at 3 wk postclip but not 6 wk, whereas baroreflex control of heart rate was attenuated at both time points (18). Clearly, one cannot assume that just because baroreflex control of heart rate has reset that baroreflex control to other vascular beds will also have reset.
| SECOND ARGUMENT AGAINST ARTERIAL BAROREFLEXES PLAYING A ROLE IN THE LONG-TERM CONTROL OF ARTERIAL PRESSURE: BARORECEPTOR DENERVATION STUDIES |
|---|
|
|
|---|
It should be not be forgotten that pressure in the SAD animals is much more variable than in baroreceptor-intact animals, with the frequency distribution curves often having long tails, indicating extremes in pressure in the SAD animals, emphasizing the importance of the arterial baroreflex in buffering rapid changes in arterial pressure. If we closely examine the frequency distribution curves of the mean arterial pressure in the SAD dogs presented by Cowley et al. it is apparent that, not only is the distribution of the pressures wider than in the intact dogs, but in 8 of the 12 SAD dogs the peak of the distribution curve (mode) is much higher than we would expect (well above 125 mmHg, whereas in the intact dogs no peak was above 125 mmHg, Figure 1 ), suggesting that in any one animal at a given time the arterial pressure is hardly "normal" in the SAD animals. We should keep in mind why it is so important that arterial pressure is tightly regulated; there is a fine line between organs receiving sufficient perfusion to meet their metabolic needs and being exposed to too low or too high pressures resulting in end-organ damage. While the mean pressure, when averaged over many days may be the same in intact and SAD animals, this does not mean that pressure is normal, with evidence that impaired baroreflex control, with increased pressure variability is associated with significant end-organ damage in the heart (52, 56) and kidneys (49, 50).
|
| WHAT ARE THE IDEAL CONDITIONS IN WHICH TO STUDY THE ROLE OF THE BAROREFLEX IN LONG-TERM PRESSURE CONTROL? |
|---|
|
|
|---|
Studies in the conscious baroreceptor-denervated animals are also often conducted under conditions in which the measurement environment was tightly constrained; for example in the studies by Cowley et al. (12) the dogs were tethered, preventing them from turning more than 360° or rolling onto their back. Given the human situation is one where the environmental inputs constantly change why should we study animal models in which we tightly control the inputs? One reason the inputs are tightly controlled is because we wish to hold constant as many of the factors liable to influence our experimental data as possible. In principle this gives the highest likelihood of seeing a significant effect. Yet the converse argument is also true: that we may see different effects when we let the inputs vary and thus we may see the sum of the different factors involved in pressure control. Howe and colleagues (22) reported that increasing dietary salt intake resulted in hypertension in SAD but not baroreceptor-intact rats. Similarly, Osborn and Hornfeldt (42) recorded arterial pressure via telemetry in Sprague-Dawley rats fed three levels of dietary salt, 0.4, 4.0 and 8.0%. By the third week of 4.0% salt, arterial pressure was elevated significantly in SAD but not sham-operated rats. By the end of the third week of 8.0% salt diet, 24-h arterial pressure was elevated 15 ± 2 mmHg above control in SAD rats compared with a 4 ± 1 mmHg increase in sham-operated rats. Hourly analysis of the final 72 h of each level of dietary salt revealed a marked effect of dietary salt on arterial pressure in SAD rats, particularly during the dark cycle when animals were active. Arterial pressure increased
20 and 30 mmHg in SAD rats over the 12-h dark cycle for 4.0 and 8.0% NaCl diets, respectively. In contrast, increased dietary salt had no effect on arterial pressure during any phase of the light or dark period in sham-operated rats. These results not only reveal the importance of the baroreceptors in modulating arterial pressure in the presence of a high salt intake but also show how important it is to record arterial pressure over 24 h.
We believe that if we are going to fully understand the role baroreflexes play in setting the mean level of blood pressure over the long-term, we need to examine the factors involved in blood pressure control for periods of weeks if not months, with 24 h/day recordings in an environment where the arterial baroreceptors are exposed to the fluctuations in pressure that accompany everyday life. While such fluctuations illustrate the ability of baroreflexes to buffer acute pressure stimuli, it is worth considering that it may be this very nature of arterial pressure that allows the baroreflexes to continue to play a role in long-term pressure control. While there is clear evidence that the arterial baroreflex resets when faced with a sustained change in arterial pressure, the question arises if this is really the type of stimuli that the arterial baroreflex is exposed to in vivo. Everyday activities such as sleeping, exercise, and eating, produce considerable changes in arterial pressure, and thus the input to the baroreceptors is never really constant. Recently, Lohmeier et al. (30) applied electrical stimulation to the carotid baroreceptors in dogs for 7 days and observed a sustained reduction in arterial pressure, suggesting that the arterial baroreflex was not resetting. It is important to note the stimulus used was not in fact constant but rather a train of stimuli for 9 min followed by a 1-min off period. Thus it is possible that the baroreflex was never in a position to be able to reset because their input was being adjusted every 9 min. Rather than criticize this approach as one that could not ascertain whether baroreflex resetting occurs, one could suggest that it better reflects the fluctuating nature of the stimuli that the arterial baroreflex would be exposed to in daily life. It is noted that Lohmeier et al. bypassed the pressure-encoding step of the arterial baroreflex by direct stimulation of the baroreceptors, and thus we can only conclude that the central component of the arterial baroreflex does not reset under such conditions of intermittent stimuli. It remains unclear whether the afferent limb of the arterial baroreflex, the baroreceptors themselves, would reset when exposed to a pressure which on average was raised, but showed continuous fluctuations.
What Variable Should We Be Studying?
If arterial baroreflexes do exert a long-term action over SNA and arterial pressure, it is possible that the mechanisms involved are quite different from those involved in the short term. Currently many researchers lump the changes in SNA into a single response and forget that the ability of the arterial baroreflex to regulate SNA is differentially controlled. One important area for future study is to determine the relative role in long-term pressure control of each the various efferent pathways under baroreflex control. It has been argued that in order for baroreflexes to exert a long-term action on arterial pressure it must be via an alteration in the renal pressure diuresis/natriuresis relationship (28). The importance of the renal nerves in long-term pressure regulation is illustrated by the point that renal denervation alone lowers arterial pressure, at least in part due to neurally mediated release of rennin (24). Similarly, our own studies in anesthetized rabbits show that low-level electrical stimulation of the renal nerves to a single kidney produces increases in arterial pressure, a response dependent on ANG II (27). Given the kidney's central role in the long-term control of arterial pressure, a key question must therefore be what is the role of the arterial baroreflex regulation of SNA to the kidney vs. other vascular beds? Only by directly recording SNA to various vascular beds are we going to be able to unravel the relative importance of each of the vascular beds in blood pressure control.
| ANG II MODELS OF HYPERTENSION: WHAT CAN WE LEARN FROM THEM? |
|---|
|
|
|---|
Our own studies in conscious animals using ANG II infusions to induce hypertension have shown clear differences in the ability of baroreflex control of heart rate and SNA to reset. Importantly these are the first studies in which within-animal long-term recordings of SNA been described. Using direct long-term recordings of renal SNA and blood pressure in rabbits, we explored the relationship between increased ANG II levels, SNA and baroreflexes (2). A 1-wk period of ANG II infusion (50 ng·kg1·min1) caused a sustained increase in arterial pressure (
18 mmHg). While ANG II is thought to act centrally to cause sympathoexcitation (60), we found ANG II caused a sustained decrease in renal SNA throughout the whole infusion (Fig. 2). Cessation of the ANG II caused blood pressure and SNA to return to control levels. The observation of sympathoinhibition during ANG II infusions is also supported by Carroll et al. (7) who measured renal norepinephrine overflow as an indirect index of renal sympathetic nerve activity. Six days of ANG II hypertension was associated with marked reductions in renal norepinephrine spillover. Our results suggest that ANG II-induced hypertension results in a sustained reduction in renal SNA that is likely to be baroreflex dependent. The heart rate to arterial pressure baroreflex response displayed evidence of the classical resetting with a rightward shift in the curve (Fig. 3). However, in the arterial pressure to SNA relationship there was no evidence of resetting (Fig. 3). There was an obvious decrease in the range of the reflex at days 2 and 7 of ANG II infusion. Significantly before the ANG II infusion the resting point of the arterial baroreflex curve lay near the steepest point of the arterial pressure-renal SNA curve, whereas during the ANG II infusion the resting point lay close to the lower plateau; thus producing an increase in arterial pressure from this point using a rapid phenylephrine infusion did not result in any further decrease SNA. The arterial pressure at half the reflex range was not altered during the ANG II infusion; in other words the overall curve was not shifted to the left or right. The gain of the curve was also unaffected, despite the decrease in range. Upon ANG II cessation, all baroreflex parameters had returned to control values when measured 3 days after stopping ANG II (Fig. 3). It was proposed that the lack of resetting of the arterial pressure to SNA curve, with the resting point lying near the lower plateau, suggests the sustained decrease in SNA during ANG II is baroreflex mediated.
|
|
The effect of ANG II-induced hypertension in baroreceptor-denervated animals also offers some interesting insights. One would predict that if the arterial baroreceptors are playing a role in buffering the increase in arterial pressure in response to ANG II, then the increase in arterial pressure in response to ANG II infusion would be greater in SAD than intact animals. Cowley and DeClue (11) were the first to test this hypothesis and found that ANG II infusion in SAD dogs caused an abruptincrease in arterial pressure, with a slower rise in pressure in the arterial baroreflex-intact dogs. However, after 28 h the mean arterial pressure was not different between the two groups of animals, leading them to conclude that while initially the arterial baroreflexes helped prevent the rise in pressure, they reset in response to the maintained infusion. Our own observations suggest that this conclusion is too simplistic. We examined the responses in intact and SAD rabbits to a 7-day infusion ANG II (50 ng·kg1·min1 iv via a miniosmotic pump). Baseline arterial pressure was not significantly different between the intact and SAD rabbits (76.0 ± 3.1 mmHg in the sham operated and 80.6 ± 1.5 mmHg in the SAD), although as expected the variability of the pressure was greater in the denervated rabbits. ANG II infusion significantly increased arterial pressure in both groups of animals. Like Cowley and DeClue (11), we found that the increase in arterial pressure tended to occur more rapidly in the SAD rabbits (Fig. 4); however, the mean increase over the 7-day infusion period was not different between the sham-operated and SAD rabbits (95.5 ± 3.2 mmHg and 96.2 ± 2.9 in the sham-operated and SAD rabbits, respectively, P = 0.79, Fig. 4). It should be pointed out that while arterial pressure in the control animals reached the same mean level as the SAD rabbits, we have already shown that ANG II causes a sustained decrease in renal SNA throughout the 7 days of infusion (2). This raises an interesting scenario: for the first 24 h of ANG II infusion arterial pressure is lower in the intact than denervated rabbits, presumably due to the buffering effects of the arterial baroreflex; however, long term there is no difference in the mean arterial pressure between the two groups of animals. What has happened? Given that renal SNA is still suppressed by
50% in the intact animals (Fig. 2), we cannot conclude that the arterial baroreflexes have reset, at least not baroreflex control of renal SNA. Does the fact that the arterial pressure in the intact and denervated rabbits is the same after 7 days of ANG II infusion suggest that the changes in renal SNA are irrelevant in long-term pressure control? Or does the slow increase in arterial pressure reflect the multitude of actions ANG II has, i.e., while the systemic vasoconstrictor actions of ANG II may cause a baroreflex-mediated decrease in SNA, these are opposed over time by the ANG-induced increase in aldosterone, sodium reabsorption, and shift in the renal fluid balance relationship (17). These results illustrate the difficulty in making assumptions about one component when we are studying a system where there are multiple effectors playing a role in the long-term pressure control.
|
|
When observing the sustained decrease in renal SNA during the 7 days of ANG II infusion, we suggested that in conscious animals, where the baroreceptors are exposed to natural variations in arterial pressure as the animal goes about its daily activities, the arterial baroreflexes may play a significant role in the control of SNA and arterial pressure in the long-term (2). These results support previous studies where a sustained decrease in renal SNA was inferred (7, 29). However, we recognize that the SNA suppression may be specific to ANG II. It is unclear whether the same changes in SNA would have occurred if a non-ANG II-based form of hypertension had been used. While ANG II does not appear to affect the arterial pressure-baroreceptor afferent activity relationship (21), there is evidence that ANG II can act within the central nervous system in a pressure-independent manner to alter the arterial baroreceptor reflex output relationship (34). Brooks and colleagues (35) have shown that the shift in the baroreflex control of heart rate and plasma norepinephrine levels they observe with ANG II infusion is largely reversed even when arterial pressure is maintained at the hypertensive level by replacing ANG II with phenylephrine. It is also worth considering what would have happened if we had used a lower dose of ANG II; would we then have seen sympathoexcitation as has been often reported (20, 45). Finally, many of the studies have followed baroreflexes and/or SNA for only a modest period of time (510 days), and it remains unclear whether baroreflex control of renal SNA would eventually reset if the administration of ANG II had been for longer. The evidence from a renal clip form of hypertension, and thus high ANG II levels, is that resetting does occur after 6 wk (18). It is also worth remembering the differential nature of sympathetic nerve activity as it does appear that the action of ANG II on renal SNA may be specific to the renal component of SNA. In our own study while we saw a sustained sympathoinhibition of renal SNA, the arterial pressure-to-heart rate relationship clearly did reset by day 2 of the ANG II infusion (2). Similarly, May and colleagues have shown that the acute intracerebroventricular administration of ANG II in sheep results in an increase in cardiac SNA (59) but a decrease in renal SNA (35). Given the importance of renal SNA in long-term pressure control, a better understanding of this differential control of renal SNA is clearly required. Such questions and caveats may in some way help to explain the apparent major discrepancy between the early studies (12) indicating the arterial baroreflexes weren't important for long-term blood pressure control from more recent studies indicating nonresetting of the arterial baroreflex (2, 33) and therefore a possible role in long-term blood pressure control.
| NEW APPROACHES NEEDED |
|---|
|
|
|---|
Currently, the most common approach for examining the role of the arterial baroreflexes in long-term pressure control is to remove one component of the reflex, using techniques such as SAD, renal denervation, sympathectomy, and ganglionic blockade. While such techniques may offer some information as to the importance of the arterial baroreflex, they are limited in their ability to allow changes to be monitored with time and they do not allow quantitative data to be collected. The drive to understand the role of baroreflexes in long-term pressure regulation is generated by the interest in understanding pathologies where it appears the arterial baroreflex is disrupted in some sense, e.g., heart failure, sleep apnea, obesity, early-stage hypertension; in each of these cases SNA tends to be increased (15, 51, 57, 61). Given that we are interested in understanding pathologies in which SNA appears to be increased, it seems a critical flaw is to assume that the responses to decreasing or removing SNA will simply be the opposite of increasing SNA. There is a clear need to focus on developing experimental paradigms/stimuli that increase arterial pressure via increasing SNA. The "chronic baroreceptor unloading" method developed by Thrasher (54) whereby a decrease in carotid sinus pressure is achieved by isolating the sinus is an excellent attempt at inducing a reflex increase in SNA and systemic arterial pressure. A disadvantage of this chronic baroreceptor unloading technique is that the preparation may not be stable, with increased flow to the carotid region with time making changes in systemic arterial pressure difficult to interpret. Measurements of blood flow above the carotid sinus, and SNA may help answer the questions as to the stability of the method.
To determine exactly the long-term roles of different pathways within the central nervous system, it is perhaps a combination of tools that is required. With the advent of the revolution in genetic manipulation, a number of new avenues for investigating the mechanisms of cardiovascular control are opened up. The use of viral vectors for gene transfer to alter the regulation of specific peptides within the brain stem is one such technique that allows the action of specific components of cardiovascular control to be studied. The use of viral vectors is promising because of its ability to locally regulate gene expression. Such tools have already shown that endothelial nitric oxide synthase acts within the nucleus of the solitary tract to chronically attenuate the gain of the arterial baroreflex (58). The use of such tools in combination with long-term recordings, whether it is of just blood pressure or in combination with SNA recordings, offers potential for a wealth of information to be determined about the effects of various peptides within specific areas of the central nervous system.
In summary, the question remains, do the arterial baroreflexes play a role in long-term pressure regulation? We suggest that the answer is yes, although we do not believe that this necessitates a radical new thinking of the role of the arterial baroreflexes. Their role predominantly is to buffer rapid changes in arterial pressure. Removal of the arterial baroreceptors alone increases the variability of arterial pressure but has no long-term effect on arterial pressure (12), in part because other neural, hormonal, and intrinsic mechanisms are available to regulate the mean level of arterial pressure. In the conscious animal, where the arterial baroreceptors are continually exposed to fluctuations in pressure associated with daily activity, it is unlikely that a sustained change in pressure will result in complete resetting of the arterial baroreflex (37), and thus the arterial baroreflexes will continue to oppose the change in pressure to some degree. Our own recent work has shown that in response to ANG-induced hypertension, renal SNA is likely to be inhibited for a period of at least 7 days (2). While this inhibition may be a specific ANG II effect, and not necessarily directly pressure dependent, it does appear to be dependent on an intact arterial baroreflex pathway (31). The inhibition of SNA may be limited to the renal bed (2, 59); however, given the crucial role of the kidneys in long-term pressure control (17), changes in renal SNA cannot be overlooked. There is a clear need to develop experimental paradigms whereby arterial pressure is manipulated and SNA monitored to a range of organs continuously over a time period of weeks to months.
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
R. L. Khan, R. Vadigepalli, M. K. McDonald, R. F. Rogers, G. R. Gao, and J. S. Schwaber Dynamic transcriptomic response to acute hypertension in the nucleus tractus solitarius Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2008; 295(1): R15 - R27. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Monahan Effect of aging on baroreflex function in humans Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2007; 293(1): R3 - R12. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Lohmeier, T. M. Dwyer, E. D. Irwin, M. A. Rossing, and R. S. Kieval Prolonged Activation of the Baroreflex Abolishes Obesity-Induced Hypertension Hypertension, June 1, 2007; 49(6): 1307 - 1314. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Sayk, C. Becker, C. Teckentrup, H.-L. Fehm, J. Struck, J. P. Wellhoener, and C. Dodt To Dip or Not to Dip: On the Physiology of Blood Pressure Decrease During Nocturnal Sleep in Healthy Humans Hypertension, May 1, 2007; 49(5): 1070 - 1076. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Fu, R. P. Shook, K. Okazaki, J. L. Hastings, S. Shibata, C. L. Conner, M. D. Palmer, and B. D. Levine Vasomotor sympathetic neural control is maintained during sustained upright posture in humans J. Physiol., December 1, 2006; 577(2): 679 - 687. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Bechtold and D. A. Scheuer Glucocorticoids act in the dorsal hindbrain to modulate baroreflex control of heart rate Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2006; 290(4): R1003 - R1011. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Persson Baroreflexes in Hypertension: A Mystery Revisited Hypertension, November 1, 2005; 46(5): 1095 - 1096. [Full Text] [PDF] |
||||
![]() |
V. L. Brooks and A. F. Sved Pressure to change? Re-evaluating the role of baroreceptors in the long-term control of arterial pressure Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2005; 288(4): R815 - R818. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||